Wikipedia - 5-alpha-reductase inhibitor5a-Reductase inhibitors (or 5-alpha-reductase inhibitors) are a group of drugs with antiandrogenic activity, used in the treatment of benign prostatic hyperplasia and androgenic (or androgenetic) alopecia. These drugs decrease the levels of available 5a-reductase prior to testosterone's binding with the enzyme, thus reducing levels of dihydrotestosterone that derives from such a bond.
[edit] Clinical use[edit] Indications5a-Reductase inhibitors are clinically used in the treatment of conditions that are exacerbated by dihydrotestosterone. To be specific, these indications may include:[1]
[edit] Adverse drug reactionsIn general, adverse drug reactions (ADRs) experienced with 5a-reductase inhibitors are dose-dependent. Common ADRs include impotence, decreased libido, and decreased ejaculate volume. Rare ADRs include breast tenderness and enlargement, and allergic reaction.[1] [edit] PharmacologyThe enzyme 5a-reductase is involved in the conversion of testosterone to the active form dihydrotestosterone by reducing the ?4,5 double-bond. In benign prostatic hyperplasia, dihydrotestosterone acts as a potent cellular androgen and promotes prostate growth; therefore, inhibiting the enzyme reduces the excessive prostate growth. In alopecia, male-pattern baldness is one of the effects of androgenic receptor activation. Thus, reducing the levels of dihydrotestosterone reduces alopecia.
Results of an enzyme assay conducted with an extract of Ganoderma lucidum (Reishi) and the enzyme 5-alpha reductase.[2]
Some compounds in nature are able to inhibit 5a-reductase, like the Reishi mushroom[2] [edit] Examples
[edit] References
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "5-alpha-reductase inhibitor". |
||||||||||||||||||||||||||||||||||||||||




